San Diego—Nutritional supplements meant to slow the progression of AMD may actually accelerate the disease in people with certain genotypes.
» What the study found
San Diego—Focal or grid laser treatment that coincides with the initiation of intravitreal ranibizumab for the treatment of DME shows results no better than when laser treatment is deferred.
» Find out more
Newark, CA—NIH recently awarded a $215,000 Small Business Technology Transfer Grant to Oraya Therapeutics to investigate how its therapy and gold nanoparticles affect the treatment of wet AMD.
» How the treatment could help
Editorial Questions? Contact the Editorial Team. Click Here.
Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.
Like
Tweet
